Entropy Wins South African Psilocin Patent Protection Through 2043
ENP: $0.029 +0.00% · MC: $47M
Entropy Neurodynamics has secured a South African patent covering proprietary crystalline forms of psilocin, extending protection through 2043 and adding to a corresponding Australian patent granted earlier this year. The company says the patent complements its TRP-8803 development program and is intended to support future development, licensing and partnership opportunities.

Comments